Increased schedule-induced polydipsia in the rat following subchronic treatment with MK-801

Schizophrenia Research

Volumn 125, Issue 1, 2011, Pages 93-98

  Hawken, Emily R ^a,b   Delva, Nicholas J ^b,c   Reynolds, James N ^b   Beninger, Richard J ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adjunctive behaviour; Animal model; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; DIZOCILPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE MODEL; DOPAMINERGIC SYSTEM; FLUID INTAKE; HIPPOCAMPUS; LONG TERM EXPOSURE; MALE; NONHUMAN; POLYDIPSIA; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING, OPERANT; DIZOCILPINE MALEATE; DRINKING; DRINKING BEHAVIOR; DRUG ADMINISTRATION SCHEDULE; MALE; NEUROPROTECTIVE AGENTS; RATS; REINFORCEMENT SCHEDULE; THIRST; TIME FACTORS;

EID: 78650267675     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.07.022     Document Type: Article

References (48)

1. Amato D., Stasi M.A., Borsini F., Nencini P. Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia. Psychopharmacology 2008, 200(2):157-165.
2. Ashby D.M., Habib D., Dringenberg H.C., Reynolds J.N., Beninger R.J. Subchronic MK-801 treatment and post-weaning social isolation in rats: differential effects on locomotor activity and hippocampal long-term potentiation. Behav Brain Res. 2010, 212(1):64-70.
3. Badiani A., Vaccaro R., Burdino R., Casini A., Valeri P., Renda T.G., Nencini P. Dissociation in the effects of the D2/D3 dopaminergic agonist quinpirole on drinking and on vasopressin levels in the rat. Neurosci. Lett. 2002, 325(2):79-82.
4. Beninger R.J., Forsyth J.K., Adel M.V., Reynolds J.N., Boegman R.J., Jhamandas K. Subchronic MK-801 deficits in rats: partial reversal by the novel nitrate GT 1061. Pharmacol. Biochem. Behav. 2009, 91(4):495-502.
5. Beninger R.J., Beuk J., Banasikowski T.J., van Adel M., Boivin G.A., Reynolds J.N. Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding. Behav. Pharmacol. 2010, 21(1):1-10.
6. Braun I., Genius J., Grunze H., Bender A., Möller H.J., Rujescu D. Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism. Schizophr. Res. 2007, 97(1-3):254-263.
7. Dawe G.S., Hwang E.H., Tan C.H. Pathophysiology and animal models of schizophrenia. Ann. Acad. Med. Singapore 2009, 38(5):425-426.
8. de Leon J.D., Verghese C., Tracy J.I., Josiassen R.C., Simpson G.M. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol. Psychiatry 1994, 35(6):408-419.
9. Devenport L.D. Schedule-induced polydipsia in rats: adrenocortical and hippocampal modulation. J. Comp. Physiol. Psychol. 1978, 92(4):651-660.
10. Didriksen M., Christensen A.V. The attenuation of schedule-induced polydipsia by dopamine blockers is not an expression of extrapyramidal side effect liability. Behav. Pharmacol. 1993, 4(3):517-522.
11. Didriksen M., Christensen A.V. The effects of amphetamine, phencyclidine, dopaminergic antagonists and atypical neuroleptics on schedule-induced polydipsia (SIP) are distinguishable. Behav. Pharmacol. 1994, 5(5):32-41.
12. Escher T., Call S.B., Blaha C.D., Mittleman G. Behavioral effects of aminoadamantane class NMDA receptor antagonists on schedule-induced alcohol and self-administration of water in mice. Psychopharmacology (Berl) 2006, 187(4):424-434.
13. Falk J.L. Schedule-induced polydipsia as a function of fixed interval length. J. Exp. Anal. Behav. 1966, 9(1):37-39.
14. Falk J.L. Schedule-induced polydipsia: type, size, and spacing of meals. J. Exp. Anal. Behav. 1967, 10(2):199-206.
15. Falk J.L. Conditions producing psychogenic polydipsia in animals. Ann. NY Acad. Sci. 1969, 157(2):569-593.
16. Flint J., Shifman S. Animal models of psychiatric disease. Curr. Opin. Genet. Dev. 2008, 18(3):235-240.
17. Flores P., Pellón R. Rate-dependency hypothesis and the rate-decreasing effects of d-amphetamine on schedule-induced drinking. Behav. Pharmacol. 1995, 6(1):16-23.
18. Flory R.K. The control of schedule induced polydipsia: frequency and magnitude of reinforcement. Learn. Motiv. 1971, 2(3):215-227.
19. Glass G.V., Hopkins K.D. Statistical Methods in Psychology and Education 1996, Allyn and Bacon, Maryland. third ed.
20. Goldman M.B. The mechanisms of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness. Brain Res. Rev. 2009, 61(2):210-220.
21. Goldman M.B., Mitchell C.P. What is the functional significance of hippocampal pathology in schizophrenia. Schizophr. Bull. 2004, 30(2):367-392.
22. Goldman M.B., Robertson G.L., Luchins D.J., Hedeker D., Pandey G.N. Psychotic exacerbations and enhanced vasopressin secretion in schizophrenics with hyponatremia and polydipsia. Arch. Gen. Psychiatry 1997, 54(5):443-449.
23. Goldman M.B., Torres I.J., Keedy S., Marlow-O'Connor M., Beenken B., Pilla R. Reduced anterior hippocampal formation volume in hyponatremic schizophrenic patients. Hippocampus 2007, 17(7):554-562.
24. Goldman M.B., Wood G., Goldman M.B., Gavin M., Paul S., Zaheer S., Fayyaz G., PIlla R.S. Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients. J. Clin. Endocrinol. Metab. 2007, 92(2):698-704.
25. Goldman M.B., Gnerlich J., Hussain N.N. Neuroendocrine responses to a cold pressor stimulus in polydipsic hyponatremic and in matched schizophrenic patients. Neuropsychopharmacolgy 2007, 32(7):1611-1621.
26. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 2004, 174(1):151-162.
27. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 2005, 10(1):40-68.
28. Herman J.P., Ostrander M.M., Mueller N.K., Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(8):1201-1213.
29. Illowsky B.P., Kirch D.G. Polydipsia and hyponatremia in psychiatric patients. Am. J. Psychiatry 1988, 145(6):675-683.
30. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999, 20(3):201-225.
31. Kahn R.S., Davis K.L. New developments in dopamine and schizophrenia. Psychopharmacology: the Fourth Generation of Progress 1995, 1193-1203. Raven Press, New York. F.E. Bloom, D.J. Kupfer (Eds.).
32. Kirov G., O'Donovan M.C., Owen M.J. Finding schizophrenia genes. J. Clin. Invest. 2005, 155(6):1440-1448.
33. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol. Psychiatry 2004, 9(6):609-620. Stanley Neuropathology Consortium.
34. Lewis D.A. Development of the primate prefrontal cortex. Neurodevelopment and Adult Psychopathology 1997, 12-30. Cambridge University Press, Cambridge. M.S. Keshavan, R.M. Murray (Eds.).
35. Lewis D.A., Volk D.W., Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl) 2004, 174(1):143-150.
36. Lopez-Grancha M., Lopez-Crespo G., Sanchez-Amate M.C., Flores P. Individual differences in schedule-induced polydipsia and the role of gabaergic and dopaminergic systems. Psychopharmacology (Berl) 2008, 197(3):487-498.
37. Luchins D.J., Nettles K.W., Goldman M.B. Anterior medial temporal lobe volumes in polydipsic schizophrenic patients with and without hypo-osmolemia: a pilot study. Biol. Psychiatry 1997, 42(9):767-770.
38. Matsumoto C., Shinkai T., De Luca V., Hwang R., Hori H., Lanktree M., Ohmori O., Kennedy J.L., Nakamura J. Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia. Int. J. Neuropsychopharmacol. 2005, 28(2):245-253.
39. Mittleman G., Rosner A.L., Schaub C.L. Polydipsia and dopamine: behavioural effects of dopamine D1 and D2 receptor agonists and antagonists. J. Pharmacol. Exp. Ther. 1994, 271(2):638-650.
40. Nettles K.W., Pesold C., Goldman M.B. Influences of the ventral hippocampal formation on plasma vasopressin, hypothalamic-pituitary-adrenal axis, and behavioral responses to novel acoustic stress. Brain Res. 2000, 858(1):181-190.
41. Schobel S.A., Kelly M.A., Corcoran C.M., Van Heertum K., Seckinger R., Goetz R., Harkavy-Friedman J., Malaspina D. Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia. Schizophr. Res. 2009, 114(1-3):110-118.
42. Segal E.F., Oden D.L., Deadwyler S.A. Schedule-induced polydipsia: effects of providing an alternate reinforcement response and of introducing a lick-contingent delay in food delivery. Psychon. Sci. 1965, 15:153-154.
43. Umbricht D. Polydipsia and hippocampal pathology. Biol. Psychiatry 1994, 36(10):708-710.
44. Wallace M., Singer G. Schedule induced behavior: a review of its generality, determinants and pharmacological data. Pharmacol. Biochem. Behav. 1976, 5(4):483-490.
45. Weinberger D.R. Neurodevelopmental perspectives on schizophrenia. Psychopharmacology: The Fourth Generation of Progress 1995, 1171-1183. Raven Press, New York. F.E. Bloom, D.J. Kupfer (Eds.).
46. Weinberger D.R., Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr. Res. 1995, 16(2):87-110.
47. Weissenborn R., Blaha C.D., Winn P., Phillips A.G. Schedule-induced polydipsia and the nucleus accumbens: electrochemical measurements of dopamine efflux and effects of excitotoxic lesions in the core. Behav. Brain Res. 1996, 75(1-2):147-158.
48. Xu Q., de la Cruz E., Anderson S.A. Cortical interneuron fate determination: diverse sources for distinct subtypes?. Cereb. Cortex 2003, 13(6):670-676.